Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert J Ossenkoppele

Showing results (111-120 of 193) with videos related to

Pageof 20
Sort By:
Blood|January 18, 2013
Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patientsRoland B Walter, Megan Othus, Alan K Burnett, et al.
Blood Advances|December 22, 2020
IGFBP7 activates retinoid acid-induced responses in acute myeloid leukemia stem and progenitor cellsNoortje van Gils, Han J M P Verhagen, Arjo Rutten, et al.
Blood|October 6, 2007
Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cellsSaskia A G M Cillessen, John C Reed, Kate Welsh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasiaBob Löwenberg, Gareth Morgan, Gert J Ossenkoppele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2005
Prognostic index for adult patients with acute myeloid leukemia in first relapseDimitri A Breems, Wim L J Van Putten, Peter C Huijgens, et al.
Leukemia Research|April 16, 2014
High class II-associated invariant chain peptide expression on residual leukemic cells is associated with increased relapse risk in acute myeloid leukemiaWillemijn van den Ancker, Marvin M van Luijn, Martine E D Chamuleau, et al.
Haematologica|February 27, 2003
Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemiaMarjolein A van der Pol, Henk J Broxterman, Jennie M Pater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation RegistryRoel J W van Kampen, Carmen Canals, Harry C Schouten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphomaSaskia A G M Cillessen, Corine J Hess, Erik Hooijberg, et al.
Blood|September 29, 2011
Autologous peripheral blood stem cell transplantation for acute myeloid leukemiaEdo Vellenga, Wim van Putten, Gert J Ossenkoppele, et al.
Pageof 20

Showing results (111-120 of 193) with videos related to

Sort By:
Pageof 20
Blood|January 18, 2013
Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patientsRoland B Walter, Megan Othus, Alan K Burnett, et al.
Blood Advances|December 22, 2020
IGFBP7 activates retinoid acid-induced responses in acute myeloid leukemia stem and progenitor cellsNoortje van Gils, Han J M P Verhagen, Arjo Rutten, et al.
Blood|October 6, 2007
Small-molecule XIAP antagonist restores caspase-9 mediated apoptosis in XIAP-positive diffuse large B-cell lymphoma cellsSaskia A G M Cillessen, John C Reed, Kate Welsh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasiaBob Löwenberg, Gareth Morgan, Gert J Ossenkoppele, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2005
Prognostic index for adult patients with acute myeloid leukemia in first relapseDimitri A Breems, Wim L J Van Putten, Peter C Huijgens, et al.
Leukemia Research|April 16, 2014
High class II-associated invariant chain peptide expression on residual leukemic cells is associated with increased relapse risk in acute myeloid leukemiaWillemijn van den Ancker, Marvin M van Luijn, Martine E D Chamuleau, et al.
Haematologica|February 27, 2003
Function of the ABC transporters, P-glycoprotein, multidrug resistance protein and breast cancer resistance protein, in minimal residual disease in acute myeloid leukemiaMarjolein A van der Pol, Henk J Broxterman, Jennie M Pater, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2011
Allogeneic stem-cell transplantation as salvage therapy for patients with diffuse large B-cell non-Hodgkin's lymphoma relapsing after an autologous stem-cell transplantation: an analysis of the European Group for Blood and Marrow Transplantation RegistryRoel J W van Kampen, Carmen Canals, Harry C Schouten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Inhibition of the intrinsic apoptosis pathway downstream of caspase-9 activation causes chemotherapy resistance in diffuse large B-cell lymphomaSaskia A G M Cillessen, Corine J Hess, Erik Hooijberg, et al.
Blood|September 29, 2011
Autologous peripheral blood stem cell transplantation for acute myeloid leukemiaEdo Vellenga, Wim van Putten, Gert J Ossenkoppele, et al.
Pageof 20